DUBLIN., Vasorum Ltd. The developer and manufacturer of the novel Celt ACD® vascular closure device has received approval of its PMA application from the US Food and Drug Administration (FDA). Celt ...
ORLANDO, FL—(UPDATED) The Amplatzer Amulet device (Abbott) seals off the left atrial appendage (LAA) better than the Watchman 2.5 or Watchman FLX devices (Boston Scientific) in patients with atrial ...
WASHINGTON, DC — A large study testing two different vascular-closure devices suggests that they are as good as manual compression for reducing vascular-site complications among patients undergoing ...
Please provide your email address to receive an email when new articles are posted on . In a head-to-head trial of the Amplatzer Amulet and Watchman FLX left atrial appendage closure devices, the ...
US & Canada, April 03, 2025 (GLOBE NEWSWIRE) -- US & Canada, Apr, 01, 2025 (GlobeNewswire) -- According to a comprehensive report from The Insight Partners, “Vascular Closure Device Market Size and ...
Austin, June 23, 2025 (GLOBE NEWSWIRE) -- Vascular Closure Devices Market Size & Growth Analysis: According to SNS Insider, the Vascular Closure Devices Market was valued at USD 1.78 billion in 2024 ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
Although wound closure is often considered a routine part of orthopedic surgery, complications such as surgical site infection, wound dehiscence and scarring can occur. When considering surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results